News | Mammography | February 27, 2019

First-of-its-kind study shows new technology helpful for women regardless of breast density

Radiologists Quickly Improve Screening Performance With 3-D Mammography

February 27, 2019 — Radiologists quickly learn to read 3-D mammography more accurately than they read standard 2-D mammograms, a first-of-its-kind study by a UC Davis researcher has found.

Published in Radiology,1 the study led by Diana Miglioretti found that radiologists who interpret traditional mammograms, which are two-dimensional, required little startup time for transitioning to reading digital breast tomosynthesis (DBT), or 3-D mammography, with improved screening accuracy.

Researchers found radiologists recalled patients for additional testing at a lower rate on DBT than they did on 2-D mammography, without sacrificing cancer detection. A patient may be recalled if there is a suspicious finding on the screening examination that requires follow-up imaging and possibly biopsy to determine if it is cancer. Three-dimensional views taken as part of a DBT screening help the radiologist confirm that some findings on 2-D images are not cancer, and so fewer patients have to be recalled. These improvements were seen regardless of the patient’s breast density.

“We found that patients with or without dense breasts benefit from lower recall rates with 3-D mammography and there is no trade off with cancer detection,” said Miglioretti, dean’s professor of biostatistics in the UC Davis Department of Public Health Sciences. “In fact, we were surprised to find that improvements in recall rates were larger in women without dense breasts.”

The study included data from 104 radiologists from 53 facilities in five U.S. states, collected by the Breast Cancer Surveillance Consortium (BCSC) to evaluate whether radiologists experience a learning curve for 3-D mammography interpretive performance. The study is the largest of its kind and represented a broad range of radiology centers and providers. It is novel because it tracked radiologists’ performance over time as they transitioned from digital mammography to DBT.

DBT takes multiple X-ray images of each breast from many angles, which are then computer assembled into a three-dimensional image of the breast that the radiologist can scroll through. The U.S. Food and Drug Administration (FDA) requires only eight hours of additional training for qualified radiologists to be able to interpret DBT studies. Researchers wondered if there was a learning curve associated with the interpretive performance of this new technology and if any improvements are sustained by radiologists over time.

“We found both breast imaging subspecialists and general radiologists improved their screening performance when they switched from 2-D to 3-D mammography,” said Miglioretti. “These improvements were sustained for at least two years after adoption of the new technology.”

Most women in the U.S. do not have their mammograms interpreted by a breast imaging subspecialist, nor do they have access to academic medical centers. The study evaluated radiologists with a mix of experience at both academic and nonacademic facilities. Both breast imaging subspecialists and general radiologists improved their interpretive performance quickly after adopting DBT, with lower recall rates and similar cancer detection rates as for digital mammography.

“Women who want to reduce their chances of being recalled for additional testing may want to ask for digital breast tomosynthesis at their next screening exam,” said Miglioretti.

For more information: www.pubs.rsna.org/journal/radiology

 

Reference

1. Miglioretti D.L., Abraham L., Lee C.I., et al. Digital Breast Tomosynthesis: Radiologist Learning Curve. Radiology, Feb. 26, 2019. https://doi.org/10.1148/radiol.2019182305


Related Content

News | Artificial Intelligence

February 28, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered solutions that enable medical providers ...

Time February 28, 2024
arrow
News | Women's Health

February 27, 2024 — Hologic, Inc. continues to deliver on its commitment to advancing women’s health by unveiling new ...

Time February 27, 2024
arrow
News | Breast Imaging

February 23, 2024 — ScreenPoint Medical is showcasing its industry leading Transpara Breast AI at the 2024 European ...

Time February 23, 2024
arrow
News | PACS

February 22, 2024 — aycan, a recognized leader in medical imaging, announced that Enspectra Health used aycan’s PACS ...

Time February 22, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Breast Imaging

February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...

Time February 20, 2024
arrow
News | FDA

February 15, 2024 — Merit Medical Systems, Inc., a global leader of healthcare technology, has received US Food and Drug ...

Time February 15, 2024
arrow
News | Breast Imaging

February 9, 2024 — An innovative breast imaging technique provides high sensitivity for detecting cancer while ...

Time February 09, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
News | Radiology Business

February 1, 2024 — Theragenics Corporation, a global leader in minimally invasive brachytherapy, interventional devices ...

Time February 01, 2024
arrow
Subscribe Now